Search research articles
Contact Us
Filters
Showing results (191-200 of 268) with videos related to
Page
of 27
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 1, 1996
NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers
A K Malhotra, D A Pinals, H Weingartner, et al.
The New England Journal of Medicine
|
August 1, 1985
Effect of naloxone on food consumption in obesity
O M Wolkowitz, A R Doran, M R Cohen, et al.
The American Journal of Psychiatry
|
February 1, 1988
Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect
R C Shelton, C N Karson, A R Doran, et al.
Biological Psychiatry
|
August 1, 1988
Single-dose naloxone acutely reduces eating in obese humans: behavioral and biochemical effects
O M Wolkowitz, A R Doran, M R Cohen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 1, 1997
Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics
A K Malhotra, D A Pinals, C M Adler, et al.
Psychopharmacology Bulletin
|
January 1, 1988
Prednisone-induced behavioral and biological changes in medically healthy volunteers
O M Wolkowitz, A Breier, A Doran, et al.
Psychoneuroendocrinology
|
January 1, 1990
Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humans
O M Wolkowitz, N M Papadopoulos, R Costello, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1993
Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study
R E Litman, W W Hong, E M Weissman, et al.
Archives of General Psychiatry
|
February 15, 2001
Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findings
R C Daly, T P Su, P J Schmidt, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
January 1, 1993
Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins
M H Rapaport, E F Torrey, C G McAllister, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 268) with videos related to
Sort By:
Page
of 27
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 1, 1996
NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers
A K Malhotra, D A Pinals, H Weingartner, et al.
The New England Journal of Medicine
|
August 1, 1985
Effect of naloxone on food consumption in obesity
O M Wolkowitz, A R Doran, M R Cohen, et al.
The American Journal of Psychiatry
|
February 1, 1988
Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect
R C Shelton, C N Karson, A R Doran, et al.
Biological Psychiatry
|
August 1, 1988
Single-dose naloxone acutely reduces eating in obese humans: behavioral and biochemical effects
O M Wolkowitz, A R Doran, M R Cohen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 1, 1997
Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics
A K Malhotra, D A Pinals, C M Adler, et al.
Psychopharmacology Bulletin
|
January 1, 1988
Prednisone-induced behavioral and biological changes in medically healthy volunteers
O M Wolkowitz, A Breier, A Doran, et al.
Psychoneuroendocrinology
|
January 1, 1990
Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humans
O M Wolkowitz, N M Papadopoulos, R Costello, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1993
Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study
R E Litman, W W Hong, E M Weissman, et al.
Archives of General Psychiatry
|
February 15, 2001
Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findings
R C Daly, T P Su, P J Schmidt, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
January 1, 1993
Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins
M H Rapaport, E F Torrey, C G McAllister, et al.
Page
of 27